Elisa Cavarsaschi

Elisa Cavarsaschi

Auto-generated profile, based on publicly available information

Elisa Cavarsaschi

School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2025 in Neurology Neuroimmunology & Neuroinflammation
Verified
Journal Article
Open access
BSBenedetta Storti
Benedetta Storti
GNGiulia Negro
Giulia Negro
GOGiorgia Orsani
Giorgia Orsani
PDPayam Tabaee Damavandi
Payam Tabaee Damavandi
MDMarco Donelli
Marco Donelli
JDJacopo C. DiFrancesco
Jacopo C. DiFrancesco
Variants of cerebral amyloid angiopathy (CAA) have been increasingly reported. Iatrogenic CAA (iCAA) is a subtype arising in patients with a history of neurosurgery. Current etiopathogenetic hypotheses focus on previous exposure to contaminated materials, such as cadaveric dura, followed by a prion-like mechanism. CAA-related inflammation (CAA-ri) represents the inflammatory variant of CAA, usually with a good response to immunosuppressive therapy. To date, the association between iCAA and CAA-ri has not been clarified yet. This study reports cases of iCAA evolving into CAA-ri, emphasizing the clinical and radiologic overlaps between these conditions. This retrospective observational study included patients with clinical and radiologic features of CAA-ri and a history of neurosurgical intervention, observed at 2 Italian neurologic centers. Patients were identified from CAA databases and screened for neurosurgical history before 1990. Eligible cases met diagnostic criteria for CAA-ri. Clinical data were anonymized and included surgical details, evidence of amyloid-β in the CNS (amyloid-PET, CSF biomarkers, genetic screening), and CAA-ri features (symptoms, imaging findings, treatment, and outcomes). We identified 6 patients with iCAA who developed clinical and instrumental features of CAA-ri during their follow-up. The mean age at neurosurgery was 17.2 years (range: <1-43) while the onset of CAA-ri occurred at 61.8 years (range: 48-79), with an average latency of 44.7 years (range: 36-59). Despite immunosuppressive treatment, 2 patients experienced a rapid decline in their clinical condition and deceased within a few months from CAA-ri onset. This study increases awareness about the potential occurrence of CAA-ri in patients with iCAA, confirming its aggressive nature and highlighting the importance of neuroinflammation in the pathogenesis of the disease. In these patients, CAA-ri seems to be associated with a severe clinical course and a poor response to steroid treatment, often resulting in a fatal outcome in the short term.

1 November 2026 in Neurology Neuroimmunology & Neuroinflammation
Verified
Journal Article
Closed access
GNGiulia Negro
Giulia Negro
MRMichele Rossi
Michele Rossi
ECElisa Cavarsaschi
Elisa Cavarsaschi
GOGiorgia Orsani
Giorgia Orsani
BSBenedetta Storti
Benedetta Storti
JDJacopo C. DiFrancesco
Jacopo C. DiFrancesco